Caroline Solas
Overview
Explore the profile of Caroline Solas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hemar V, Bouchet S, Ribeiro E, Prier P, Elleau C, Solas C, et al.
J Antimicrob Chemother
. 2024 Sep;
79(12):3354-3355.
PMID: 39347710
No abstract available.
2.
Petit P, Touret F, Driouich J, Cochin M, Luciani L, Bernadin O, et al.
Heliyon
. 2024 May;
10(10):e30862.
PMID: 38803975
The SARS-CoV-2 pandemic has highlighted the need for broad-spectrum antiviral drugs to respond promptly to viral emergence. We conducted a preclinical study of molnupiravir (MOV) against SARS-CoV-2 to fully characterise...
3.
Kreins A, Roux E, Pang J, Cheng I, Charles O, Roy S, et al.
Clin Immunol
. 2024 Jan;
259:109901.
PMID: 38218209
Chronic human norovirus (HuNoV) infections in immunocompromised patients result in severe disease, yet approved antivirals are lacking. RNA-dependent RNA polymerase (RdRp) inhibitors inducing viral mutagenesis display broad-spectrum in vitro antiviral...
4.
Ragonnet G, Laroche H, Neant N, Benkouiten S, Dos Santos M, Faucher-Zaegel O, et al.
Br J Clin Pharmacol
. 2024 Jan;
90(3):895-899.
PMID: 38163749
Antiretroviral therapy administration is challenging in patients with HIV requiring enteral nutrition. There are limited pharmacokinetic data available regarding the absorption of crushed rilpivirine (RPV) and its impact on drug...
5.
Pelletier R, Gicquel T, Carvelli J, Balaz P, Pelissier-Alicot A, Morel I, et al.
Int J Legal Med
. 2023 Dec;
138(3):815-822.
PMID: 38117418
N-Benzylphenethylamine derivatives are 5-HT2A receptor agonists with hallucinogenic properties, including NBOMe (N-(2-methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethan-1-amine) and NBOH (2-(((2,5-dimethoxyphenethyl)amino)methyl)phenol). We reported here the case of a 23-year-old man who presented a serotoninergic syndrome and...
6.
Lemaitre F, Lagoutte-Renosi J, Gagnieu M, Parant F, Venisse N, Gregoire M, et al.
Br J Clin Pharmacol
. 2023 Aug;
90(1):264-273.
PMID: 37602480
Aims: Dolutegravir (DTG) and rilpivirine (RPV) dual therapy is now recommended as a switch option in virologically suppressed HIV patients. Literature suggests that virological failure with dual therapy could possibly...
7.
Bekegnran C, Driouich J, Breuer J, Barthelemy K, Giocanti M, de Lamballerie X, et al.
Biomed Chromatogr
. 2023 Jun;
37(9):e5689.
PMID: 37349975
Favipiravir, a broad-spectrum RNA-dependent RNA polymerase inhibitor, is currently being evaluated in preclinical and clinical studies for the treatment of various infectious diseases including COVID-19. We developed an ultra-performance liquid...
8.
Becam J, Martin E, Pouradier G, Doudka N, Solas C, Guilhaumou R, et al.
Toxics
. 2023 May;
11(5).
PMID: 37235278
We report a case of accidental nicotine intoxication following transdermal exposure in a 22-year-old man with no medical history, who worked in a company manufacturing e-liquids for electronic cigarettes. He...
9.
Becam J, Pelissier-Alicot A, Doudka N, Richez M, Solas C, Fabresse N
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 May;
1224:123739.
PMID: 37172558
The objective of this study was to develop and validate a simple method using liquid chromatography hyphenated to high resolution mass spectrometry (HRMS) allowing both the performance of a non-targeted...
10.
Leblond P, Tresch-Bruneel E, Probst A, Neant N, Solas C, Sterin A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046681
Preclinical data support the activity of celecoxib and fluvastatin in high-grade (HGG) and low-grade gliomas (LGG). A phase I trial (NCT02115074) was designed to evaluate the safety of this combination...